GlassScriptPhysician profile
Jonathan Pierpoline
NPI 1336732692
$7,572.86
in general payments reported to CMS, 2019-2025
9 companies · $3,338 in 2025
The $3,338 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $325 · 2023: $1,628 · 2024: $2,281 · 2025: $3,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,097 · Education: $662 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,097.27 |
| Education | $661.97 |
| Travel and Lodging | $488.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,469.17 | 2022-2025 | Inspire |
| Depuy Synthes Sales INC. | $1,247.48 | 2023-2025 | Trumatch, Na, Matrixmandible |
| Stryker Corporation | $1,085.07 | 2023-2025 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Smartlock |
| Axogen | $949.55 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Medical Device Business Services, INC. | $661.97 | 2023-2024 | |
| Acera Surgical, INC. | $593.70 | 2024-2025 | Restrata Wound Matrix |
| Kerecis Limited | $419.55 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Access Pro Medical, LLC | $130.36 | 2025 | Matriderm |
| Integra Lifesciences Corporation | $16.01 | 2023 | Integra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Pierpoline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.